Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02651324 · ClinicalTrials.gov registry record · Phase 4

Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis

A Phase 4 study, sponsored by Albany Medical College.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target

NCT02651324: Completed Phase 4 study, sponsored by Albany Medical College.

NCT02651324 is a Phase 4 study that has completed, run by Albany Medical College. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02651324, a Phase 4 study, has completed, sponsored by Albany Medical College.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target

Study Summary

This study hypothesizes that the addition of a low-dose ketamine infusion to usual post-operative pain management will improve pain control as evidenced by an improvement in post-operative pain scores for patients undergoing spinal fusion for idiopathic scoliosis.

Primary Outcome

All the patients and parent will fill out a survey grading their level of satisfaction with their post-operative pain management. Patient Satisfaction Score from a scale of 1 - 4 was used - 1. Unsatisfied 2. Moderately satisfied 3 - Generally satisfied 4 - Very satisfied No other subscales were included.

Interventions

  • OTHER Placebo
  • DRUG Ketamine

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-05
Est. Completion 2017-12
Phase Phase 4
Albany Medical College

52 total trials

What the finished NCT02651324 record still lists

NCT02651324 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02651324 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02651324 about?

NCT02651324 is a clinical study titled "Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis". This study hypothesizes that the addition of a low-dose ketamine infusion to usual post-operative pain management will improve pain control as evidenced by an improvement in post-operative pain scores for patients undergoing spinal fusion for idiopathic scoliosis.

What is the current status of trial NCT02651324?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2013-05. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02651324?

The interventions under investigation include: Placebo (OTHER), Ketamine (DRUG).

Who is sponsoring clinical trial NCT02651324?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02651324's enrollment target sits among peer trials

50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02651324, the US trial registry maintained by the National Library of Medicine. NCT02651324 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.